Furthermore, the effectiveness of this therapy is highly dependent on the genetic properties of the tumor, namely, the methylation status of the O-6-methylguanine-DNA methyltransferase (MGMT) promotor [2]. The gene discussed is MGMT; the disease is neoplasm.